Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Brain Anomalies in Children with Severe Factor VIII Deficiency- a Pilot Study

Ahmad Al-Huniti, MD, Lyndsay A Harshman, MD, Marci Novak, Peggy Nopoulos, MD, Janice M Staber, MD

Blood (2019) 134 (Supplement_1): 1121.

https://doi.org/10.1182/blood-2019-131804

Published: 2019

Journal Articles

Exploring Anemia's Impact on Brain Microstructure, Volume, Functional Connectivity, Iron and Cognitive Performance

Soyoung Choi, BA, Sharon H O'Neil, Anand A Joshi, PhD, Xin Miao, PhD, Jian Li, PhD, Justin P Haldar, PhD, Thomas Coates, MD, Richard M Leahy, PhD, John C Wood, MD PhD

Blood (2019) 134 (Supplement_1): 3553.

https://doi.org/10.1182/blood-2019-129544

Published: 2019

Journal Articles

Association of Sickle Cell Trait with Measures of Cognitive Function and Dementia in African Americans

Chen Nemin, BS, Christina Caruso, MD, Alvaro Alonso, MD PhD, Vimal K. Derebail, MD, Abhijit V Kshirsagar, MD, Richey Sharrett, MD DrPH, Nigel S. Key, MBChB, FRCP, Rebecca Gottesman, MD PhD, Megan Grove, MS, Jan Bressler, PhD, Eric Boerwinkle, PhD, B. Gwen Windham, MD MHS, Thomas H Mosley, Jr., PhD, Hyacinth I Hyacinth, MDPhDMPH

Blood (2018) 132 (Supplement 1): 1099.

https://doi.org/10.1182/blood-2018-99-109832

Published: 2018

Journal Articles

Hemoglobin Level and Platelet Size Predicts Grey and White Matter Volume Loss Measured By Tensor Based Morphology in Sickle Cell Disease

Soyoung Choi, BA, Adam M Bush, MS, Matt Borzage, PhD, Anand Joshi, PhD, Thomas D. Coates, MD, Richard Leahy, PhD, John C Wood, MD PhD

Blood (2016) 128 (22): 2481.

https://doi.org/10.1182/blood.V128.22.2481.2481

Published: 2016

Journal Articles

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Odianosen Eigbire-Molen, Deepika S. Darbari, MD, Maria R. Ponisio, MD, Mikhail V. Milchenko, PhD, Mark J. Rodeghier, PhD, James F. Casella, MD, Robert McKinstry, MD PhD, Michael R. DeBaun, MD MPH

Blood (2015) 126 (23): 546.

https://doi.org/10.1182/blood.V126.23.546.546

Published: 2015

Journal Articles

Elevated Cerebral Metabolic Oxygen Consumption in Sickle Cell Disease

Adam M Bush, BS, Matthew Borzage, BS, Soyoung Choi, BS, Thomas Coates, MD, John C Wood, MD PhD

Blood (2014) 124 (21): 2706.

https://doi.org/10.1182/blood.V124.21.2706.2706

Published: 2014

Journal Articles

Elevated Cerebral Blood Oxygen Extraction in Non-Transfused Sickle Cell Disease Patients

Adam M Bush, BS, Matthew Borzage, BS, Soyoung Choi, BS, Thomas Coates, MD, John C Wood, MD PhD

Blood (2014) 124 (21): 1387.

https://doi.org/10.1182/blood.V124.21.1387.1387

Published: 2014

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J. Hutton, MD, Michael K Racke, MD, Uday R. Popat, M.D., Steven M. Devine, MD, George E. Georges, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Meagan Spychala, Noha Lim, PhD, Sachin Malhotra, PhD, Deborah Phippard, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2012) 120 (21): 962.

https://doi.org/10.1182/blood.V120.21.962.962

Published: 2012

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J Hutton, MD, Michael K Racke, MD, Uday R Popat, MD, Steven M. Devine, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Lisa Wruck, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2011) 118 (21): 3075.

https://doi.org/10.1182/blood.V118.21.3075.3075

Published: 2011

Journal Articles

Thrombomodulin-Dependent Protein C Activator Treatment Improves the Short-Term Outcome of Experimental Ischemic Stroke in Mice.

Andras Gruber, MD, Patricia D. Hurn, PhD, Sawan Hurst, BS, Leslie Bush, MS, Ulla M. Marzec, MS, Erik Tucker, BS, Stephen R. Hanson, PhD, Enrico Di Cera, MD

Blood (2006) 108 (11): 895.

https://doi.org/10.1182/blood.V108.11.895.895

Published: 2006

NARROW

Brain Anomalies in Children with Severe Factor VIII Deficiency- a Pilot Study

Exploring Anemia's Impact on Brain Microstructure, Volume, Functional Connectivity, Iron and Cognitive Performance

Association of Sickle Cell Trait with Measures of Cognitive Function and Dementia in African Americans

Hemoglobin Level and Platelet Size Predicts Grey and White Matter Volume Loss Measured By Tensor Based Morphology in Sickle Cell Disease

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Elevated Cerebral Metabolic Oxygen Consumption in Sickle Cell Disease

Elevated Cerebral Blood Oxygen Extraction in Non-Transfused Sickle Cell Disease Patients

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Thrombomodulin-Dependent Protein C Activator Treatment Improves the Short-Term Outcome of Experimental Ischemic Stroke in Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only